Quipt Home Medical, a player in the healthcare equipment and supplies sector, has been catching the eye of private investors lately. With its stock trading on the NASDAQ, the company has generated buzz, particularly with an analyst consensus rating of "Strong Buy." This optimism is reflected in the five strong buy recommendations from analysts, suggesting confidence in the company's future prospects. However, it's important to note that the company reported a loss in its recent fiscal year ending in September, which might give some investors pause.
The stock's valuation metrics present a mixed picture. The valuation real value stands at $4.65, while the naive expected forecast value is $3.09, indicating potential discrepancies in market perception versus intrinsic value. Additionally, the possible upside price of $6.06 suggests room for growth, but investors should weigh this against the potential downside price of $0.12. As private investors consider their positions, these factors, along with the company's strategic direction and market conditions, will be crucial in making informed decisions. We focus on examining Quipt Home Medical's stock price trends and how they relate to various microeconomic factors. By using predictive analytics, we develop daily price indicators for Quipt and assess them alongside relevant market influences. Given the current economic climate, Quipt might present unexpected developments before its next earnings report. Despite this uncertainty, we remain optimistic about a potential recovery.
The successful prediction of Quipt Home
stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published
stock prices of traded companies, such as Quipt Home Medical, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at
the intrinsic value of Quipt Home based on Quipt Home hews, social hype, general headline patterns, and widely used
predictive technical indicators. We also calculate exposure to Quipt Home's
market risk, different
technical and
fundamental indicators, relevant financial multiples and ratios, and then
comparing them to Quipt Home's related companies.
Use Technical Analysis to project Quipt expected Price
Quipt Home technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Quipt Home technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Quipt Home trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions.
More Info...Quipt Home Gross Profit
Quipt Home Gross Profit growth is one of the most critical measures in evaluating the company. The Gross Profit growth rate is calculated simply by comparing Quipt Home previous period's values with its current period's values. Each time period you're measuring should be of equal lengths the increase or decrease, in a company's Gross Profit between two periods. Here we show Quipt Home Gross Profit growth over the last 10 years. Please check Quipt Home's
gross profit and other
fundamental indicators for more details.
Going after Quipt Financials
The modest gains experienced by current holders of Quipt Home created some momentum for private investors as it was traded today as low as
2.68 and as high as
3.02 per share. The company executives have been quite successful in maneuvering the stock at opportune times to take advantage of all market conditions in
November. The stock standard deviation of daily returns for 90 days investing horizon is currently 2.97. The current volatility is consistent with the ongoing market swings in
November 2024 as well as with Quipt Home unsystematic, company-specific events.
| 2021 | 2022 | 2023 | 2024 (projected) |
Days Sales Outstanding | 42.75 | 42.76 | 38.49 | 53.69 | Ptb Ratio | 1.79 | 1.78 | 1.6 | 1.59 |
Current Deferred Revenue Breakdown
Quipt Home Current Deferred Revenue yearly trend continues to be comparatively stable with very little volatility. Current Deferred Revenue is likely to outpace its year average in 2024. Current Deferred Revenue usually refers to revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends. At this time, Quipt Home's Current Deferred Revenue is comparatively stable compared to the past year.
| 2017 | 1.82 Million |
| 2018 | 1.44 Million |
| 2019 | 3.29 Million |
| 2020 | 7.34 Million |
| 2021 | 3.04 Million |
| 2022 | 4.49 Million |
| 2023 | 5.16 Million |
| 2024 | 5.42 Million |
Timing is everything. With Quipt Home Medical's market capitalization standing at $130 million and a significant debt load of $97.96 million, private investors might want to take a closer look at their portfolios. The company's high price-to-earnings ratio of 98.25X suggests that the stock might be overvalued, especially when coupled with a modest return on equity of 0.05. However, with a cash flow from operations of $40.54 million, there is a silver lining that indicates strong operational efficiency. Given these mixed signals, reassessing holdings in Quipt Home Medical could be a prudent move for those looking to balance risk and reward.
Our take on today Quipt Home gain
Quipt Home Medical's stock has experienced a promising rise today, with its volatility narrowing to 8.69. This reduction in volatility suggests a stabilization in the stock's price movements, which could be appealing to investors seeking more predictable returns. As the company navigates the healthcare sector, this newfound stability might draw interest from those looking for opportunities in medical services. It's a development worth monitoring, as it could signal a shift towards more consistent growth for Quipt Home Medical. Currently, the stock shows below-average downside deviation, with an Information Ratio of 0.02 and a Jensen Alpha of 0.03.
Understanding market volatility trends can help investors time their trades, as volatility indicators measure Quipt Home's stock risk against market fluctuations in both bullish and bearish periods.Quipt Home Medical's recent uptick has certainly caught the attention of investors, but the question remains whether this momentum can be sustained. With an analyst target price estimated at $10.17 and a strong buy consensus from analysts, there is a compelling case for potential growth. The stock's valuation real value of 4.65 suggests that there might be room for appreciation, especially if the company continues to deliver on its growth strategies. However, as with any investment, it's crucial to weigh these optimistic projections against market conditions and company performance. Keeping an eye on these factors will be key for investors considering a stake in Quipt Home Medical..
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Quipt Home Medical. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
[email protected]